These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11747468)
1. Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIV. Pang X; Zhang M; Dayton AI BMC Microbiol; 2001; 1():28. PubMed ID: 11747468 [TBL] [Abstract][Full Text] [Related]
2. Development of Dengue virus type 2 replicons capable of prolonged expression in host cells. Pang X; Zhang M; Dayton AI BMC Microbiol; 2001; 1():18. PubMed ID: 11580862 [TBL] [Abstract][Full Text] [Related]
3. Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication. Leardkamolkarn V; Sirigulpanit W; Chotiwan N; Kumkate S; Huang CY Virus Res; 2012 Feb; 163(2):552-62. PubMed ID: 22197424 [TBL] [Abstract][Full Text] [Related]
4. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
5. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684 [TBL] [Abstract][Full Text] [Related]
6. Establishment and Application of Flavivirus Replicons. Kümmerer BM Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532 [TBL] [Abstract][Full Text] [Related]
7. Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes. Varnavski AN; Khromykh AA Virology; 1999 Mar; 255(2):366-75. PubMed ID: 10069962 [TBL] [Abstract][Full Text] [Related]
8. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus. Aberle JH; Aberle SW; Kofler RM; Mandl CW J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582 [TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant. Wen Y; Trinh HV; Linton CE; Tani C; Norais N; Martinez-Guzman D; Ramesh P; Sun Y; Situ F; Karaca-Griffin S; Hamlin C; Onkar S; Tian S; Hilt S; Malyala P; Lodaya R; Li N; Otten G; Palladino G; Friedrich K; Aggarwal Y; LaBranche C; Duffy R; Shen X; Tomaras GD; Montefiori DC; Fulp W; Gottardo R; Burke B; Ulmer JB; Zolla-Pazner S; Liao HX; Haynes BF; Michael NL; Kim JH; Rao M; O'Connell RJ; Carfi A; Barnett SW PLoS One; 2018; 13(4):e0194266. PubMed ID: 29698406 [TBL] [Abstract][Full Text] [Related]
10. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2. Lai CY; Hu HP; King CC; Wang WK J Biomed Sci; 2008 Jan; 15(1):15-27. PubMed ID: 17768670 [TBL] [Abstract][Full Text] [Related]
11. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes. Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299 [TBL] [Abstract][Full Text] [Related]
12. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies. Ahmad A; Ladha A; Cohen EA; Menezes J Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893 [TBL] [Abstract][Full Text] [Related]
13. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys. Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group. Corey L; McElrath MJ; Weinhold K; Matthews T; Stablein D; Graham B; Keefer M; Schwartz D; Gorse G J Infect Dis; 1998 Feb; 177(2):301-9. PubMed ID: 9466515 [TBL] [Abstract][Full Text] [Related]
15. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response. Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins. Anderson MJ; Porter DC; Moldoveanu Z; Fletcher TM; McPherson S; Morrow CD AIDS Res Hum Retroviruses; 1997 Jan; 13(1):53-62. PubMed ID: 8989427 [TBL] [Abstract][Full Text] [Related]
17. Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand. Sailaja G; Husain S; Nayak BP; Jabbar AM J Immunol; 2003 Mar; 170(5):2496-507. PubMed ID: 12594275 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity. Shata MT; Hone DM J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease. Fultz PN; Stallworth J; Porter D; Novak M; Anderson MJ; Morrow CD Virology; 2003 Oct; 315(2):425-37. PubMed ID: 14585346 [TBL] [Abstract][Full Text] [Related]
20. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Fouts TR; Tuskan RG; Chada S; Hone DM; Lewis GK Vaccine; 1995 Dec; 13(17):1697-705. PubMed ID: 8719522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]